Pharm-Analyt Labor Ges.m.b.H
Pharm-Analyt Labor Ges.m.b.H is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Multicentre, open-label, phase 1/2 study of LB-208, selective antagonist of the serotonin 5-hydroxytryptamine receptor 1B (HTR1B), in adults with relapse or refractory (r/r) acute myeloid leukaemia (AML) and r/r higher-risk (HR) myelodysplastic syndrome (MDS)
Sponsor Aop Orphan Pharmaceuticals GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Randomized, Double-blind, Vehicle-controlled Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of Topically Applied TCP-25 in Patients with Epidermolysis Bullosa
Sponsor Xinnate AB
- Start (EU)
- Latest update
- Estimated end
Open-label, single-arm, non-controlled trial to evaluate the safety and tolerability of treprostinil sodium in children below the age of 18 with pulmonary arterial hypertension (PAH)
Sponsor Aop Orphan Pharmaceuticals GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Pharm-Analyt Labor Ges.m.b.H?
The 2026-10-09 snapshot links Pharm-Analyt Labor Ges.m.b.H to 3 distinct CTIS trials. Recorded services include Laboratory services, Blood samples and BM aspirates for PK, IDO1 activity (kynurenine/tryptophan ratio). These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Pharm-Analyt Labor Ges.m.b.H?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Pharm-Analyt Labor Ges.m.b.H conducted?
The linked trials record locations in 10 countries, including Spain, France, Austria, Germany, Greece. These are trial locations, not confirmed office locations or countries where Pharm-Analyt Labor Ges.m.b.H delivered services.
What can this page tell me about Pharm-Analyt Labor Ges.m.b.H's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Pharm-Analyt Labor Ges.m.b.H. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Pharm-Analyt Labor Ges.m.b.H.